Thumbnail Image
Publication

Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant

Citations
Altmetric:
Video URL
Date
2021-10-17
Author
Abu-Raddad, Laith J, Chemaitelly, Hiam, Ayoub, Houssein H, Yassine, Hadi M, Benslimane, Fatiha M, Al Khatib, Hebah A, Tang, Patrick, Hasan, Mohammad R, Coyle, Peter, AlMukdad, Sawsan, Al Kanaani, Zaina, Al Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F, Nasrallah, Gheyath K, Al Kuwari, Mohamed Ghaith, Butt, Adeel A, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H, Al Khal, Abdullatif, Bertollini, Roberto
Collections
Biomedical Sciences
COVID-19 Research
Show all metadata
Files
Thumbnail Image
Clinical infectiou diseasesd Severity Criticality and Fatality of the.pdf
Adobe PDF, 874 KB
Abstract
Beta (B.1.351) variant COVID-19 disease was investigated in Qatar. Compared to Alpha (B.1.1.7) variant, odds of progressing to severe disease were 1.24-fold (95% CI: 1.11-1.39) higher for Beta. Odds of progressing to critical disease were 1.49-fold (95% CI: 1.13-1.97) higher. Odds of COVID-19 death were 1.57-fold (95% CI: 1.03-2.43) higher.
URI
http://hdl.handle.net/10576/25635